US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 3, 2017 (10 years ago)

GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21)…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed dissolution specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specification rates for the 10 hour testing point.

What was recalled

GlipiZIDE Extended-release tablets, 2.5 mg, 30-count carton (NDC 68084-295-21), Individual dose (NDC 68084-395-11), Rx Only, Packaged and Distributed by American Health Packaging, Columbus, Ohio 43217, NDC 68084-295-21

Recalling firm
Amerisource Health Services
NDC code
68084-295-21
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0520-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Glipizide recalls

See all